CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sarepta Therapeutics (NASDAQ:SRPT), a developer of innovative RNA-targeted therapeutics, today announced that management will be presenting a company overview and update at the 2015 Morgan Stanley Global Healthcare Conference in New York, NY. Edward Kaye, Sarepta’s interim chief executive officer and chief medical officer, will represent the company in a fireside chat on Thursday, September 17 at 4:40 PM Eastern Time.
Help employers find you! Check out all the jobs and post your resume.
